Pharmaceutical and biotechnology major Wockhardt said on Tuesday that India Ratings and Research (Ind-Ra) has placed its long-term issuer rating of BB plus on rating watch evolving (RWE) with a negative outlook.The RWE follows Wockhardt's divestment of a portion of its domestic branded business to Dr Reddy's Laboratories Ltd for Rs 1,850 crore.The divested business comprises 62 products in multiple therapeutic areas such as respiratory, neurology, vitamins, minerals and supplements, dermatology, gastroenterology... Читать дальше...